Last reviewed · How we verify

NCT04170517: ProFET

Serum Progesterone Levels on the Day of Frozen Embryo Transfer (FET) and Pregnancy Outcomes

Completed Last updated 29 August 2022
What this trial tests

trial testing Measurement of serum progesterone on the day of FET in Infertility in 402 participants. Completed in 31 December 2021.

Timeline
2 January 2020
Primary endpoint
28 February 2021
31 December 2021

Quick facts

Lead sponsorCARE Fertility UK
StatusCompleted
Study typeOBSERVATIONAL
Enrollment402
Start date2 January 2020
Primary completion28 February 2021
Estimated completion31 December 2021
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

CARE Fertility UK

Who can join

Eligibility, female only, with Infertility or Infertility, Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Frozen embryo transfer (FET) cycles have become more common in recent years due to a push towards elective single embryo transfer (SET). While it is known that progesterone supplementation during the luteal phase improves clinical pregnancy rates, there is a paucity of prospective data on the impact of serum progesterone levels on pregnancy outcomes in FET cycles. This multicentre prospective cohort study aims to investigate the association between serum progesterone levels on the day of FET and pregnancy outcomes, and to determine a serum progesterone cut-off value above which clinical pregnancy and live birth are more likely to occur. Women undergoing ART-FET cycles at CARE Fertility clinics in the UK will be recruited and their serum progesterone measured on the day of frozen embryo transfer. Follow-up data will be stored in electronic patient records and analysed to determine whether a low serum progesterone level on the day of FET adversely affects ART outcomes.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of frozen embryo transfer regimen on the association between serum progesterone and live birth: a multicentre prospective cohort study (ProFET).
    Melo P, Wood S, Petsas G, Chung Y, et al · · 2022 · cited 15× · PMID 36518987 · DOI 10.1093/hropen/hoac054

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

Other CARE Fertility UK trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04170517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing